Viruses and human cancer: From detection to causality

Cancer Letters

Volumn 305, Issue 2, 2011, Pages 218-227

  Sarid, Ronit ^a   Gao, Shou Jiang ^b  

^a BAR ILAN UNIVERSITY   (Israel)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cancer viruses; Causality; Epstein Barr virus, EBV; Hepatitis B virus, HBV; Hepatitis C virus, HCV; Human papillomavirus, HPV; Human T cell lymphotropic virus type 1, HTLV 1; Kaposi's sarcoma associated herpesvirus, KSHV; Merkel cell polyomavirus (MCPyV); Virus discovery

Indexed keywords

GANCICLOVIR; HEPATITIS B VACCINE; WART VIRUS VACCINE;

BURKITT LYMPHOMA; CONDYLOMA ACUMINATUM; DNA MICROARRAY; EPIDERMODYSPLASIA VERRUCIFORMIS; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN T CELL LEUKEMIA VIRUS 1; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MERKEL CELL TUMOR; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; T CELL LEUKEMIA; TUMOR VIRUS; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; POLYOMAVIRUS;

EID: 79955465352     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.09.011     Document Type: Review

References (93)

1. Javier R.T., Butel J.S. The history of tumor virology. Cancer Res. 2008, 68:7693-7706.
2. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens - part B: biological agents. Lancet Oncol. 2009, 10:321-322.
3. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
4. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 118:3030-3044.
5. de Martel C., Franceschi S. Infections and cancer: established associations and new hypotheses. Crit. Rev. Oncol. Hematol. 2009, 70:183-194.
6. Burkitt D.P. The discovery of Burkitt's lymphoma. Cancer 1983, 51:1777-1786.
7. Bornkamm G.W. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin. Cancer Biol. 2009, 19:351-365.
8. Kutok J.L., Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 2006, 1:375-404.
9. Pattle S.B., Farrell P.J. The role of Epstein-Barr virus in cancer. Expert. Opin. Biol. Ther. 2006, 6:1193-1205.
10. Shah K.M., Young L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin. Microbiol. Infect. 2009, 15:982-988.
11. McClain K.L., Leach C.T., Jenson H.B., Joshi V.V., Pollock B.H., Parmley R.T., DiCarlo F.J., Chadwick E.G., Murphy S.B. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. New Engl. J. Med. 1995, 332:12-18.
12. Klein E., Kis L.L., Klein G. Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene 2007, 26:1297-1305.
13. Blumberg B.S., Larouze B., London W.T., Werner B., Hesser J.E., Millman I., Saimot G., Payet M. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am. J. Pathol. 1975, 81:669-682.
14. Blumberg B.S., Alter H.J., Visnich S. A "new" antigen in leukemia sera. JAMA 1965, 191:541-546.
15. Prince A.M., Szmuness W., Michon J., Demaille J., Diebolt G., Linhard J., Quenum C., Sankale M. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int. J. Cancer 1975, 16:376-383.
16. Blumberg B.S. Hepatitis B virus and the control of hepatocellular carcinoma. IARC Sci. Publ. 1984, 243-261.
17. Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981, 2:1129-1133.
18. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26:6266-6273.
19. Franceschi S., Raza S.A. Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett. 2009, 286:5-8.
20. Ciuffo G. Innesto positivo con infiltrado di verrucae volgare. Ital. Mal. Venereol. 1907, 48:12-15.
21. Human papillomaviruses, IARC Monogr. Eval. Carcinog Risks Hum. 90 (2007), 1-636.
22. Rous P., Beard J.W. The progression to carcinoma of virus-induced rabbit papillomas (Shope). J. Exp. Med. 1935, 62:523-548.
23. Olson C., Pamukcu A.M., Brobst D.F., Kowalczyk T., Satter E.J., Price J.M. A urinary bladder tumor induced by a bovine cutaneous papilloma agent. Cancer Res. 1959, 19:779-782.
24. Sykes J.A., Dmochowski L., Russell W.O. Bovine ocular squamous cell carcinoma. II. Tissue culture studies of papilloma. Proc. Soc. Exp. Biol. Med. 1959, 101:192-193.
25. Jablonska S., Dabrowski J., Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 1972, 32:583-589.
26. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.
27. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481-492.
28. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77:7415-7419.
29. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 1981, 78:6476-6480.
30. Gallo R.C. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 2005, 24:5926-5930.
31. Matsuoka M., Jeang K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7:270-280.
32. Boxus M., Willems L. Mechanisms of HTLV-1 persistence and transformation. Brit. J. Cancer 2009, 101:1497-1501.
33. Feuer G., Green P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005, 24:5996-6004.
34. Grassmann R., Aboud M., Jeang K.T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985.
35. Mahieux R., Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol. Biol. (Paris) 2009, 57:161-166.
36. Alter H.J., Purcell R.H., Holland P.V., Popper H. Transmissible agent in non-A, non-B hepatitis. Lancet 1978, 1:459-463.
37. Tabor E., Gerety R.J., Drucker J.A., Seeff L.B., Hoofnagle J.H., Jackson D.R., April M., Barker L.F., Pineda-Tamondong G. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1978, 1:463-466.
38. Popper H., Dienstag J.L., Feinstone S.M., Alter H.J., Purcell R.H. The pathology of viral hepatitis in chimpanzees. Virchows Arch. A Pathol. Anat. Histol. 1980, 387:91-106.
39. Houghton M. Discovery of the hepatitis C virus. Liver Int. 2009, 29(Suppl. 1):82-88.
40. Beral V., Peterman T.A., Berkelman R.L., Jaffe H.W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?. Lancet 1990, 335:123-128.
41. Beral V., Bull D., Darby S., Weller I., Carne C., Beecham M., Jaffe H. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992, 339:632-635.
42. Cohen A., Wolf D.G., Guttman-Yassky E., Sarid R. Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit. Rev. Clin. Lab. Sci. 2005, 42:101-153.
43. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
44. Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science 1993, 259:946-951.
45. Cesarman E., Chang Y., Moore P.S., Said J.W. Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. New Engl. J. Med. 1995, 332:1186-1191.
46. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
47. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 1996, 2:342-346.
48. Gao S.J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C.R., Saah A., Phair J., et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 1996, 2:925-928.
49. Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 1996, 2:918-924.
50. Gao S.J., Kingsley L., Hoover D.R., Spira T.J., Rinaldo C.R., Saah A., Phair J., Detels R., Parry P., Chang Y., Moore P.S. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. New Engl. J. Med. 1996, 335:233-241.
51. Simpson G.R., Schulz T.F., Whitby D., Cook P.M., Boshoff C., Rainbow L., Howard M.R., Gao S.J., Bohenzky R.A., Simmonds P., et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-1138.
52. Whitby D., Howard M.R., Tenant-Flowers M., Brink N.S., Copas A., Boshoff C., Hatzioannou T., Suggett F.E., Aldam D.M., Denton A.S. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
53. Moore P.S., Kingsley L.A., Holmberg S.D., Spira T., Gupta P., Hoover D.R., Parry J.P., Conley L.J., Jaffe H.W., Chang Y. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
54. Codish S., Abu-Shakra M., Ariad S., Zirkin H.J., Yermiyahu T., Dupin N., Boshoff C., Sukenik S. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma. Am. J. Hematol. 2000, 65:310-314.
55. Bollen J., Polstra A., Van Der Kuyl A., Weel J., Noorduyn L., Van Oers M., Cornelissen M. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report. BMC Blood Disord 2003, 3:3.
56. Engels E.A., Frisch M., Goedert J.J., Biggar R.J., Miller R.W. Merkel cell carcinoma and HIV infection. Lancet 2002, 359:497-498.
57. Pastrana D.V., Tolstov Y.L., Becker J.C., Moore P.S., Chang Y., Buck C.B. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009, 5:e1000578.
58. Laude H.C., Jonchère B., Maubec E., Carlotti A., Marinho E., Couturaud B., Peter M., Sastre-Garau X., Avril M.F., Dupin N., Rozenberg F. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog. 2010, 6:e1001076.
59. Abend J.R., Jiang M., Imperiale M.J. BK virus and human cancer: innocent until proven guilty. Semin. Cancer Biol. 2009, 19:252-260.
60. Woolhouse M.E., Howey R., Gaunt E., Reilly L., Chase-Topping M., Savill N. Temporal trends in the discovery of human viruses. Proc. Biol. Sci. 2008, 275:2111-2115.
61. Kellam P. Molecular identification of novel viruses. Trends Microbiol. 1998, 6:160-165.
62. Wang D., Coscoy L., Zylberberg M., Avila P.C., Boushey H.A., Ganem D., DeRisi J.L. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. USA 2002, 99:15687-15692.
63. Tang P., Chiu C. Metagenomics for the discovery of novel human viruses. Future Microbiol. 2010, 5:177-189.
64. Breitbart M., Haynes M., Kelley S., Angly F., Edwards R.A., Felts B., Mahaffy J.M., Mueller J., Nulton J., Rayhawk S., et al. Viral diversity and dynamics in an infant gut. Res. Microbiol. 2008, 159:367-373.
65. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 2005, 102:12891-12896.
66. Breitbart M., Hewson I., Felts B., Mahaffy J.M., Nulton J., Salamon P., Rohwer F. Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 2003, 185:6220-6223.
67. Breitbart M., Rohwer F. Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing. Biotechniques 2005, 39:729-736.
68. Zhou F., Li Q., Gao S.J. A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes. Nucleic Acids Res. 2009, 37:e2.
69. Maginnis M.S., Atwood W.J. JC virus: an oncogenic virus in animals and humans?. Semin. Cancer Biol. 2009, 19:261-269.
70. Shah K.V. SV40 and human cancer: a review of recent data. Int. J. Cancer 2007, 120:215-223.
71. Jarviluoma A., Ojala P.M. Cell signaling pathways engaged by KSHV. Biochim. Biophys. Acta 2006, 1766:140-158.
72. Greene W., Kuhne K., Ye F., Chen J., Zhou F., Lei X., Gao S.J. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res. 2007, 133:69-127.
73. Ganem D. KSHV and the pathogenesis of Kaposi's sarcoma: listening to human biology and medicine. J. Clin. Invest. 2010, 120:939-949.
74. Schulz T.F. Cancer and viral infections in immunocompromised individuals. Int. J. Cancer 2009, 125:1755-1763.
75. Franco E.L., Correa P., Santella R.M., Wu X., Goodman S.N., Petersen G.M. Role and limitations of epidemiology in establishing a causal association. Semin. Cancer Biol. 2004, 14:413-426.
76. Goncalves D.U., Proietti F.A., Ribas J.G., Araujo M.G., Pinheiro S.R., Guedes A.C., Carneiro-Proietti A.B. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin. Microbiol. Rev. 2010, 23:577-589.
77. Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., Nolt K., Nelson K.E., Strathdee S.A., Johnson L., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000, 284:450-456.
78. Castello G., Scala S., Palmieri G., Curley S.A., Izzo F. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin. Immunol. 2010, 134:237-250.
79. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010, 42(Suppl 3):S206-S214.
80. Fredericks D.N., Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996, 9:18-33.
81. Hill A.B. The environment and disease: association or causation?. Proc. Royal Soc. Med. 1965, 58:295-300.
82. Sarid R., Olsen S.J., Moore P.S. Kaposi's sarcoma-associated herpesvirus epidemiology, virology, and molecular biology. Adv. Virus Res. 1999, 52:139-232.
83. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25.
84. Schlaberg R., Choe D.J., Brown K.R., Thaker H.M., Singh I.R. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl. Acad. Sci. USA 2009, 106:16351-16356.
85. Rodriguez J.J., Goff S.P. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J. Virol. 2010, 84:2556-2562.
86. Varthakavi V., Browning P.J., Spearman P. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J. Virol. 1999, 73:10329-10338.
87. Guo H.G., Pati S., Sadowska M., Charurat M., Reitz M. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J. Virol. 2004, 78:9336-9342.
88. Sun Q., Matta H., Chaudhary P.M. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology 2005, 2:9.
89. Martin M.P., Carrington M. Immunogenetics of viral infections. Curr. Opin. Immunol. 2005, 17:510-516.
90. Hjalgrim H., Rostgaard K., Johnson P.C., Lake A., Shield L., Little A.M., Ekstrom-Smedby K., Adami H.O., Glimelius B., Hamilton-Dutoit S., et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA 2010, 107:6400-6405.
91. Li X., Fasano R., Wang E., Yao K.T., Marincola F.M. HLA associations with nasopharyngeal carcinoma. Curr. Mol. Med. 2009, 9:751-765.
92. Chene A., Donati D., Orem J., Mbidde E.R., Kironde F., Wahlgren M., Bejarano M.T. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin. Cancer Biol. 2009, 19:411-420.
93. Chang E.T., Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidem. Biomar. Prev. 2006, 15:1765-1777.